These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1091050

  • 1. Use of intravenous methylprednisolone in transplantation of diabetics.
    Woods JE, Palumbo PJ, Johnson WJ, Anderson CF, Frohnert PP.
    Transplant Proc; 1975 Mar; 7(1):89-92. PubMed ID: 1091050
    [No Abstract] [Full Text] [Related]

  • 2. The clinical use of steroids in pancreatic transplantation.
    Gliedman ML, Tellis V, Soberman R, Rifkin H, Freed SZ, Veith FJ.
    Transplant Proc; 1975 Mar; 7(1):93-8. PubMed ID: 1091051
    [No Abstract] [Full Text] [Related]

  • 3. Bolus doses of steroids in transplantation.
    Kountz SL, Rao TK.
    Proc Clin Dial Transplant Forum; 1974 Mar; (4):90-5. PubMed ID: 4619669
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of kidney-graft rejection with high doses of methylprednisolone].
    Kaslíková J, Jirka J, Reneltová I, Kocandrle V.
    Vnitr Lek; 1977 Jun; 23(6):540-3. PubMed ID: 329567
    [No Abstract] [Full Text] [Related]

  • 5. End-stage diabetic nephropathy. Discussion: problems in transplantation.
    Kidney Int Suppl; 1974 Oct; (1):133-40. PubMed ID: 4619128
    [No Abstract] [Full Text] [Related]

  • 6. Intravenous methylprednisolone at the time of renal transplantation.
    Heaton A, Wilkinson R, Elliott RW, Ward MK, Taylor RM, Proud G.
    Proc Eur Dial Transplant Assoc; 1983 Oct; 19():482-7. PubMed ID: 6348749
    [Abstract] [Full Text] [Related]

  • 7. Is HLA matching worthwhile in pancreatic transplantation?
    Hopt UT, Büsing M, Schareck W, Pfeffer F, Irkin I, Becker HD.
    Transplant Proc; 1992 Jun; 24(3):909-10. PubMed ID: 1604664
    [No Abstract] [Full Text] [Related]

  • 8. Methyl prednisolone in the treatment of renal transplant rejection.
    Clarke AG, Salaman JR.
    Clin Nephrol; 1974 Jun; 2(6):230-4. PubMed ID: 4141287
    [No Abstract] [Full Text] [Related]

  • 9. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A randomized, controlled, prospective study of the effect of alternate-day prednisone on renal transplant function.
    McDonald FD, Horensten ML, Schork MA, Turcotte JG.
    Proc Clin Dial Transplant Forum; 1972 Feb; 2():5-7. PubMed ID: 4619674
    [No Abstract] [Full Text] [Related]

  • 19. Discrepancy between renal and pancreatic rejection in combined transplantation.
    Frisk B, Hedman L, Andersson C, Nyberg G, von Schenck H, Brynger H.
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2835-6. PubMed ID: 2468244
    [No Abstract] [Full Text] [Related]

  • 20. An immunological comparison of pancreas transplants alone in nonuremic patients versus simultaneous pancreas/kidney transplants in uremic diabetic patients.
    Gruessner RW, Dunn DL, Tzardis PJ, Tomadze G, Adamec M, Moudry-Munns K, Sutherland DE.
    Transplant Proc; 1990 Aug; 22(4):1581. PubMed ID: 2202123
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.